Ovarian cancer chemotherapy

(1), ovarian cancer-chemotherapy drug commonly used drug <BR> melphalan (PAM) 0.2 ^ / ㎏ d, oral, 4 ~ for a course on the 5th, rest four to six weeks after duplication. Thiotepa (161-169) 10 ^ / times, intramuscular or intravenous injection, used five times, every other day to once a total of 300 ~ 500 days for an induction course. 6 to 8 weeks under the condition repeat. Cyclophosphamide (CTX) 50 ~ 100 ^ / day, oral, 7 ~ 10 Tianyi treatment, two weeks after duplication. Or 400 ^ / day, intravenous, oral to four days. Adriamycin (ADM) 50 ~ 70 ^ / ㎡, intravenous injection. Every three weeks.
(2), and malignant ovarian tumor joint chemical treatment of ovarian cancer chemotherapy are better response. In recent years the chemical treatment of tumors faster progress in the treatment of ovarian cancer Habitat has an important place to improve the treatment of ovarian cancer play a positive role as a surgical adjuvant therapy, commonly used in the preoperative, intraoperative and postoperative, but often require a longer period of intermittent medication, and the human body toxicity also sometimes larger. In most cases, it is difficult to ovarian cancer surgery primary tumor and metastasis consider chemical treatment based treatment.

Tags: body, cancer, cases, chemotherapy, days, drug, eat, injection, intravenous, malignant, metastasis, ovarian, positive, response, surgery, surgical, therapy, time, toxicity, treatment, tumor, tumors

Complications

Common complications of ovarian cancer tumor rupture, hemorrhage, secondary infection, anemia, cancer of the intestine cancer and intestinal infarction colic.

Tags: abdominal, age, anti, benign, body, breast, cancer, carcinoma, cases, cause, cell, chemotherapy, cyst, cystic, cysts, diagnosis, early, eat, examination, gene, grams, increased, malignant, mass, ovarian, pain, patients, pelvic, response, risk, second, surgery, symptoms, syndrome, tea, therapy, time, treatment, tumor, tumors, usually, uterine, women

Recurrent ovarian cancer may reoperation

Health, will be right recurrent ovarian cancer surgery and chemotherapy again whether there has been significant controversy. Fourth Military Medical University Xijing Hospital director of obstetrics and gynecology professor Detang, has nearly 10 years of the 38 treated patients with recurrent epithelial ovarian cancer clinical data were analyzed retrospectively after that, again recurrent ovarian cancer surgery and chemotherapy, can further improve the survival rate of patients.

Tags: cancer, cases, chemotherapy, clinical, early, eat, ovarian, patients, rate, surgery, survival, therapy, treatment, tumor, tumors

Early ovarian cancer surgical staging important clinical value

A scholar from the Netherlands led multinational collaborative research suggest that the early epithelial ovarian cancer surgical staging, can predict whether the patients have residual ovarian cancer and the need for postoperative adjuvant chemotherapy.

Tags: age, cancer, carcinoma, cases, cell, chemotherapy, cisplatin, clinical, early, examination, group, ovarian, patients, poor, prognosis, rate, residual, staging, surgery, surgical, survival, therapy, time, tumor

Complete remission after isolation of patients with recurrent ovarian cancer viable again cytoreductive surgery

Denmark Gronloud such report, as paclitaxel plus platinum chemotherapy after complete remission in patients with ovarian cancer, if recurrence of a solitary lesion again cytoreductive surgery may improve survival. (Eur J Surg Oncol 2005,31:67)

In the retrospective study selected criteria: 1 Guide to the residual initial stage operation and confirmed by histological examination of epithelial ovarian cancer; (2) complete remission after first-line treatment; 3. Imaging confirmed pots peritoneal metastasis; (4) Surgical resection of lesions for the purpose.

Tags: age, cancer, cases, cell, chemotherapy, eat, examination, metastasis, ovarian, paclitaxel, patients, rate, resection, residual, study, surgery, surgical, survival, therapy, time, treatment, tumor, tumors

Common symptoms of ovarian cancer diagnosis and

In recent decades, the treatment of gynecologic cancer progress has been made, but only the ovarian cancer there is no significant improvement. The incidence of ovarian cancer Habitat Gynecologic Oncology third, but it was the first fatality rate. Its cause high mortality due to the growth of ovarian cancer site concealment, not be seen directly, patients still in the early stages of the lack of simple and practical method of diagnosis. Most (about 70%) have been newly diagnosed patients with peritoneal metastasis pots. Currently taken by surgery, radiotherapy, chemotherapy and immunotherapy for the treatment of Chinese medicine integrated with the right therapy, in the treatment of advanced worse still, it is difficult to avoid recurrence. But by early diagnosis and treatment of patients with ovarian cancer prognosis is quite different. Case in epithelial ovarian cancer, according to statistics, the five-year survival rate, 80% for stage I, 40% for Stage II; While Ⅲ period just below 5%. Visibility early detection, early diagnosis and treatment of patients with ovarian cancer is a lifetime event.

Tags: abdominal, age, annex, anti, bleeding, cancer, carcinoma, cases, cause, chemotherapy, clinical, cyst, cystic, diagnosis, diet, early, eat, ert, examination, family, fat, growth, gynecological, history, incidence, increased, life, malignant, mass, metastasis, method, oppression, ovarian, pain, patients, pelvic, poor, prognosis, protein, quality, radiotherapy, rate, reduce, resection, surface, surgery, survival, symptoms, therapy, time, treatment, tumor, tumors, women

Experience with ovarian cancer

Treatment of ovarian cancer is still surgery and chemotherapy, although postoperative adjuvant systemic chemotherapy has been the effect certainly, but in some patients because of poor health and not systemic tolerance of the boil, and in some patients for fear of adverse reactions of chemotherapy automatically abandon further treatment, which greatly affects the quality of life and survival rate , an increase of ovarian cancer recurrence possible. The TCM adjuvant treatment of patients with chemotherapy can improve and the tolerance level of immunity and, therefore, Chinese medicine treatment of ovarian cancer has been more and more attention.

Tags: age, bleeding, cancer, cause, chemotherapy, cisplatin, clinical, drug, drugs, eat, ert, gene, injection, intravenous, knowledge, life, ovarian, patients, poor, prognosis, quality, rate, second, surgery, survival, symptoms, therapy, time, treatment, tumor, tumors

Recurrent ovarian cancer chemotherapy new method - conventional chemotherapy drug efficacy forecast molecular targeted chemotherapy

Ovarian cancer is the worst prognosis of gynecologic tumors. Patients with advanced epithelial ovarian cancer five-year survival rates generally below 30%, mainly in patients with relapsing most (about 75%), relapse after chemotherapy to poor results.

For the treatment of recurrent ovarian cancer chemotherapy drugs many, no less than 10 species, but only clinical remission rate of 20% to 30%, no progress median survival time (PFS) for 2 to 6 months, the median overall survival (OS) for six to 12 months. Therefore, to improve the efficacy of chemotherapy drugs delay, but the development of new drugs is very difficult, efficient use of existing drugs is an effective way to <BR>.

Tags: cancer, cases, chemotherapy, cisplatin, clinical, drug, drugs, early, eat, exploration, gene, group, method, ovarian, p53, paclitaxel, patients, pmtc, poor, positive, prognosis, rate, second, study, survival, taxol, therapy, time, treatment, tumor, tumors

Ovarian cancer rehabilitation period Conditioning

(1) life Conditioning
1, the personal attention sometimes, suitable living environment, adequate exercise, not overstrain. Particularly in long-term therapy, should rest, and maintain physical strength, should be nutrient-rich diet, with attention to the change in the weather changes clothes to avoid bacteria, viruses and other infections.
2, the appropriate useful life of physical and mental health, excessive, harmful to patients. However, during chemotherapy after surgery and not sex life, to question the basic physical state after the resumption before the beginning. Terminally ill patients should avoid sexual life.
(2) diet conditioning
Ovarian cancer eating conditioning is very important. After surgical treatment, clinical seen qi deficiency, spleen and stomach slump, the existing lack of nutrients, organisms dysfunction. Thus in modulating diet, we should pay attention to proper nutritional supplements, heat, to the high-protein, high-vitamin food, but also conditioning the spleen and stomach function, exciting Wei Qi, restore chemical gas source, acquired strengthening of the party. In addition to food choices milk, eggs, the average patient to eat more fresh vegetables, fruits, protein and various vitamins, blah mother pork. Ovarian tumors after serving more attention should still Tiaojing body, nourishing the liver and kidney of goods, such as pomegranates, Mangosteen, loquat fruit, fig, banana, lemon, Longan, grapes, walnuts, mulberry, black sesame, watermelons, Melon, black fungus, watery gruel, yam flour, Lotus, chestnut, mung bean, Chinese prickly ash, placenta, carp, crucian carp, eggs, milk and so on. Diet also used conditioning.
(3) psychotropic
Maintain a healthy psychological state and optimistic mood is conducive to the normal endocrine regulatory activities, which will help enhance ovarian cancer effect. Practice has proved that where the spirit of optimism and confidence than adequate treatment, and doctors with better efficacy patients better, otherwise poor. Correct pessimism, negative psychological state and inspire incentive to overcome disease patients establish the confidence to achieve good results.

Tags: age, body, cancer, chemotherapy, clinical, confidence, diet, eat, eggs, life, ovarian, patients, physical, poor, protein, psychological, surgery, surgical, therapy, time, treatment, tumor, tumors

Treatment of ovarian cancer chemotherapy new program

Researchers reported that the joint use of both cisplatin and paclitaxel chemotherapy drug for ovarian cancer achieved better clinical remission rate and a higher survival rate, this new program has become advanced ovarian cancer patients with standard treatment programs.

From the European Organization for Cancer Research and Treatment of Dr Piccart, a group of researchers across the Atlantic to the two large-scale clinical trials group that cisplatin and paclitaxel (TP) both chemotherapy treatment of advanced ovarian cancer with significant advantages.

Tags: age, anti, cancer, chemotherapy, cisplatin, clinical, drug, eat, grams, group, history, ovarian, paclitaxel, patients, rate, study, survival, therapy, treatment, tumor, tumors